Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
SAILIFE
₹1,265
₹1227.40
₹1287.00
₹776.25
₹1260.00
Markets Today
Historical Performance
As of 10-07-2026 20:25, Sai Life Science Ltd. share price today is ₹0, with a change of ₹-1234.40 (-100.00%) from the previous close of ₹1234.4. The stock opened at ₹1234.4 and traded between ₹1227.4 and ₹1287, with a total traded volume of 905328 shares. The company has a market capitalization of ₹26204.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1260 and ₹776.25, respectively.
Sai Life Science Ltd. valuation metrics include a P/E ratio of 75.1, EPS of ₹16.63, and book value of ₹10.60. Profitability indicators show ROE of 14.04%. Sai Life Science Ltd. has reported revenue of ₹2192.49 Cr and net profit of ₹348.91 Cr.
Sai Life Science Ltd. technical indicators include Day RSI at 57.28, Day MFI at 60.6, Day ADX at 22.34. Additional indicators include Commodity Channel Index (CCI) at 25.3 and Williams %R at -34.22. Momentum indicators show Day MACD at 19.85, Day MACD Signal Line at 24.9, DayATR at 40.65. Rate of Change indicators for Sai Life Science Ltd. include ROC125 at 33.93 and ROC21 at 0.38.
Exponential moving averages include EMA5 at ₹1226.2, EMA10 at ₹1225.8, EMA12 at ₹1224.4, EMA20 at ₹1214.4, EMA26 at ₹1204.5, EMA50 at ₹1161.8, EMA100 at ₹1090.9, EMA200 at ₹1000.2. Simple moving averages include SMA5 at ₹1228.2, SMA10 at ₹1232.6, SMA20 at ₹1220.1, SMA30 at ₹1202.1, SMA50 at ₹1162.6, SMA100 at ₹1071.1, SMA150 at ₹1007.5, SMA200 at ₹976.4.
Support levels for Sai Life Science are placed at First Support ₹1208.60, Second Support ₹1182.80, Third Support ₹1165.60. Resistance levels are seen at First Resistance ₹1251.60, Second Resistance ₹1268.80, Third Resistance ₹1294.60. Sai Life Science Ltd. shareholding pattern shows promoter holding at 34.61%, FII holding at 21.17%, DII holding at 0%, public holding at 12.69%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 594.34 | 549.18 | 526.67 | 483.04 | 567.01 |
| Operating Expense | 426.20 | 370.21 | 386.82 | 370.04 | 413.11 |
| Operating Profit | 168.14 | 178.97 | 139.85 | 113 | 153.90 |
| Depreciation | 41.16 | 40.60 | 36.21 | 34.32 | 34.10 |
| Interest | 6.16 | 8.06 | 7.70 | 10.70 | 9.16 |
| Tax | 34.32 | 32.84 | 27.92 | 19.61 | 30.53 |
| Net Profit | 102.53 | 97.63 | 82.95 | 58.37 | 89.94 |
Research Type
MTF , Short Term
Buy Range
₹1,271.60 - ₹0
Target Price
₹1,398
Stop Loss
₹1,207
Target Date
20 Jul 26
Potential Returns
9.94 %
₹1265.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 35.2 | 35.2 | 35.2 | 34.9 | 34.7 | 34.6 |
| FII | 11.7 | 12.4 | 14.6 | 22.5 | 21.4 | 21.2 |
| DII | 12 | 13.2 | 21.6 | 29.9 | 31.4 | 31.5 |
| Public | 41.1 | 39.2 | 28.6 | 12.6 | 12.5 | 12.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.2 L | 2.35 L | 51.04% |
| Week | 1.48 L | 2.8 L | 53.01% |
| 1 Month | 2.34 L | 4.55 L | 51.36% |
| 6 Month | 3.41 L | 6.89 L | 49.53% |
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Increasing profits every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,429 | ₹754.95 | ₹1,805 | ₹2,523 | ₹176.50 |
| % Change | 1.55% | 0.39% | -0.25% | -0.36% | 2.62% |
| Revenue TTM (₹ Cr) | ₹1,753.96 | ₹2,124.33 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹246.74 | ₹591.79 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 94.30 | 71.60 | 37.10 | 54.70 | -70.30 |
| 1 Year Return | 190.14 | 31.93 | 43.82 | 0.21 | -14.62 |
| ROCE | 24.32 | 27.56 | 25.65 | 14.32 | 2.29 |
Acutaas Chemicals Ltd.
₹ 3390.00
-1.99%
Gland Pharma Ltd.
₹ 2475.00
+0.22%
Laurus Labs Ltd.
₹ 1535.50
+1.86%
Alkem Laboratories Ltd.
₹ 5676.00
+0.49%
Biocon Ltd.
₹ 418.25
+3.64%
Divi's Laboratories Ltd.
₹ 6830.50
+0.26%
Granules India Ltd.
₹ 887.00
+0.56%
Ajanta Pharma Ltd.
₹ 3366.00
+1.77%
Zydus Lifesciences Ltd.
₹ 1152.10
-0.60%
Glenmark Pharmaceuticals Ltd.
₹ 2284.50
+0.76%
Wockhardt Ltd.
₹ 1812.80
-1.01%
Aurobindo Pharma Ltd.
₹ 1568.90
-1.17%
Sun Pharmaceutical Industries Ltd.
₹ 1932.90
-0.30%
Neuland Laboratories Ltd.
₹ 19478.00
-0.33%
Ipca Laboratories Ltd.
₹ 1780.10
+0.55%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2420.00
-1.00%
AstraZeneca Pharma India Ltd.
₹ 8115.00
+0.01%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2433.00
-0.30%
Pfizer Ltd.
₹ 4720.00
+2.83%
Abbott India Ltd.
₹ 27340.00
+2.13%
Torrent Pharmaceuticals Ltd.
₹ 4890.00
-0.17%
Lupin Ltd.
₹ 2496.00
-0.29%
Dr. Reddy's Laboratories Ltd.
₹ 1246.90
-1.78%
Cipla Ltd.
₹ 1442.00
+0.05%
By signing up I certify terms, conditions & privacy policy